| Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ... The lancet HIV 5 (3), e116-e125, 2018 | 237 | 2018 |
| Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: an interrupted time series analysis MJ Siedner, JD Kraemer, MJ Meyer, G Harling, T Mngomezulu, P Gabela, ... BMJ open 10 (10), e043763, 2020 | 174 | 2020 |
| Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS … CC Iwuji, J Orne-Gliemann, J Larmarange, N Okesola, F Tanser, ... PLoS medicine 13 (8), e1002107, 2016 | 161 | 2016 |
| Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial … CC Iwuji, J Orne-Gliemann, F Tanser, S Boyer, RJ Lessells, F Lert, J Imrie, ... Trials 14, 1-15, 2013 | 124 | 2013 |
| What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? D Havlir, S Lockman, H Ayles, J Larmarange, G Chamie, T Gaolathe, ... Journal of the International AIDS Society 23 (2), e25455, 2020 | 111 | 2020 |
| Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster‐randomized trial in rural South Africa M Plazy, KE Farouki, C Iwuji, N Okesola, J Orne‐Gliemann, J Larmarange, ... Journal of the International AIDS Society 19 (1), 20913, 2016 | 90 | 2016 |
| Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study CC Iwuji, D Churchill, Y Gilleece, HA Weiss, M Fisher BMC public health 13, 1-9, 2013 | 79 | 2013 |
| Linkage to HIV care after home‐based HIV counselling and testing in sub‐Saharan Africa: a systematic review E Ruzagira, K Baisley, A Kamali, S Biraro, H Grosskurth, ... Tropical medicine & international health 22 (7), 807-821, 2017 | 68 | 2017 |
| Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the … S Boyer, C Iwuji, A Gosset, C Protopopescu, N Okesola, M Plazy, B Spire, ... AIDS care 28 (sup3), 39-51, 2016 | 67 | 2016 |
| The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012-2016 C Iwuji, J Orne-Gliemann, E Balestre, J Larmarange, R Thiébaut, F Tanser, ... 21st International AIDS Conference (AIDS 2016), 2016 | 61 | 2016 |
| Impact of chromosomal instability on colorectal cancer progression and outcome B Orsetti, J Selves, C Bascoul-Mollevi, L Lasorsa, K Gordien, F Bibeau, ... BMC cancer 14, 1-13, 2014 | 56 | 2014 |
| Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria RJ Lessells, PC Mutevedzi, CC Iwuji, ML Newell JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (1), e17-e24, 2014 | 50 | 2014 |
| Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal J Orne-Gliemann, J Larmarange, S Boyer, C Iwuji, N McGrath, ... BMC public health 15, 1-14, 2015 | 49 | 2015 |
| Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor–containing antiretroviral … S Bertagnolio, L Hermans, MR Jordan, S Avila-Rios, C Iwuji, A Derache, ... The Journal of Infectious Diseases 224 (3), 377-388, 2021 | 44 | 2021 |
| Impact of next-generation sequencing defined human immunodeficiency virus pretreatment drug resistance on virological outcomes in the ANRS 12249 treatment-as-prevention trial A Derache, CC Iwuji, K Baisley, S Danaviah, AG Marcelin, V Calvez, ... Clinical Infectious Diseases 69 (2), 207-214, 2019 | 43 | 2019 |
| Retention in care trajectories of HIV-positive individuals participating in a universal test-and-treat program in rural South Africa (ANRS 12249 TasP Trial) A Gosset, C Protopopescu, J Larmarange, J Orne-Gliemann, N McGrath, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (4), 375-385, 2019 | 42 | 2019 |
| The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu‐Natal (South Africa) J Larmarange, MH Diallo, N McGrath, C Iwuji, M Plazy, R Thiébaut, ... Journal of the International AIDS Society 21, e25128, 2018 | 42 | 2018 |
| Virological outcomes of second-line protease inhibitor–based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing … D Collier, C Iwuji, A Derache, T de Oliveira, N Okesola, A Calmy, F Dabis, ... Clinical infectious diseases 64 (8), 1006-1016, 2017 | 40 | 2017 |
| Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa CE Oldenburg, T Bärnighausen, F Tanser, CC Iwuji, V De Gruttola, ... Reviews of Infectious Diseases 63 (4), 548-554, 2016 | 39 | 2016 |
| “It is better to die”: experiences of traditional health practitioners within the HIV treatment as prevention trial communities in rural South Africa (ANRS 12249 TasP trial) M Moshabela, T Zuma, J Orne-Gliemann, C Iwuji, J Larmarange, ... Aids Care 28 (sup3), 24-32, 2016 | 36 | 2016 |
